Generate Biomedicines, Inc. (GENB) Pre-Tax Margin
- 2026-06-30: Pre-Tax Margin -1064.33%.
- 2026-03-31: Pre-Tax Margin -853.90%.
- 2025-06-30: Pre-Tax Margin -559.70%.
- 2025-03-31: Pre-Tax Margin -501.91%.
Complete source-backed pre-tax margin history.
- Available history
- 2025-03-31 to 2026-06-30
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2026-06-30 | -1064.33% |
| 2026-03-31 | -853.90% |
| 2025-06-30 | -559.70% |
| 2025-03-31 | -501.91% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |